Logo image of GEVO

GEVO INC (GEVO) Stock Fundamental Analysis

NASDAQ:GEVO - Nasdaq - US3743964062 - Common Stock - Currency: USD

1.52  -0.1 (-6.17%)

After market: 1.56 +0.04 (+2.63%)

Fundamental Rating

2

Overall GEVO gets a fundamental rating of 2 out of 10. We evaluated GEVO against 211 industry peers in the Oil, Gas & Consumable Fuels industry. While GEVO seems to be doing ok healthwise, there are quite some concerns on its profitability. GEVO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year GEVO has reported negative net income.
In the past year GEVO has reported a negative cash flow from operations.
In the past 5 years GEVO always reported negative net income.
In the past 5 years GEVO always reported negative operating cash flow.
GEVO Yearly Net Income VS EBIT VS OCF VS FCFGEVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -13.17%, GEVO is not doing good in the industry: 90.20% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -15.75%, GEVO is doing worse than 81.37% of the companies in the same industry.
Industry RankSector Rank
ROA -13.17%
ROE -15.75%
ROIC N/A
ROA(3y)-11.11%
ROA(5y)-18.09%
ROE(3y)-12.96%
ROE(5y)-21.17%
ROIC(3y)N/A
ROIC(5y)N/A
GEVO Yearly ROA, ROE, ROICGEVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

The Gross Margin of GEVO (2.81%) is worse than 80.88% of its industry peers.
The Profit Margin and Operating Margin are not available for GEVO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GEVO Yearly Profit, Operating, Gross MarginsGEVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

4

2. Health

2.1 Basic Checks

GEVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GEVO has more shares outstanding
The number of shares outstanding for GEVO has been increased compared to 5 years ago.
The debt/assets ratio for GEVO is higher compared to a year ago.
GEVO Yearly Shares OutstandingGEVO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
GEVO Yearly Total Debt VS Total AssetsGEVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

GEVO has an Altman-Z score of 0.32. This is a bad value and indicates that GEVO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.32, GEVO is doing worse than 70.59% of the companies in the same industry.
GEVO has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
GEVO's Debt to Equity ratio of 0.13 is fine compared to the rest of the industry. GEVO outperforms 75.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 0.32
ROIC/WACCN/A
WACC7.94%
GEVO Yearly LT Debt VS Equity VS FCFGEVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 8.25 indicates that GEVO has no problem at all paying its short term obligations.
With an excellent Current ratio value of 8.25, GEVO belongs to the best of the industry, outperforming 93.63% of the companies in the same industry.
A Quick Ratio of 8.05 indicates that GEVO has no problem at all paying its short term obligations.
GEVO has a better Quick ratio (8.05) than 94.12% of its industry peers.
Industry RankSector Rank
Current Ratio 8.25
Quick Ratio 8.05
GEVO Yearly Current Assets VS Current LiabilitesGEVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

5

3. Growth

3.1 Past

The earnings per share for GEVO have decreased by -9.68% in the last year.
The Revenue has grown by 16.53% in the past year. This is quite good.
GEVO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.14% yearly.
EPS 1Y (TTM)-9.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)16.53%
Revenue growth 3Y45.88%
Revenue growth 5Y-12.14%
Sales Q2Q%-56.6%

3.2 Future

GEVO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.65% yearly.
Based on estimates for the next years, GEVO will show a very strong growth in Revenue. The Revenue will grow by 66.00% on average per year.
EPS Next Y-19.37%
EPS Next 2Y-1%
EPS Next 3Y-10.96%
EPS Next 5Y45.65%
Revenue Next Year-12.49%
Revenue Next 2Y198.42%
Revenue Next 3Y137.06%
Revenue Next 5Y66%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GEVO Yearly Revenue VS EstimatesGEVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
GEVO Yearly EPS VS EstimatesGEVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -1K -2K -3K

0

4. Valuation

4.1 Price/Earnings Ratio

GEVO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GEVO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GEVO Price Earnings VS Forward Price EarningsGEVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GEVO Per share dataGEVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

GEVO's earnings are expected to decrease with -10.96% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1%
EPS Next 3Y-10.96%

0

5. Dividend

5.1 Amount

GEVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GEVO INC

NASDAQ:GEVO (2/21/2025, 8:23:24 PM)

After market: 1.56 +0.04 (+2.63%)

1.52

-0.1 (-6.17%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-06 2025-03-06/amc
Inst Owners22.03%
Inst Owner Change-99.03%
Ins Owners4.43%
Ins Owner Change-0.34%
Market Cap363.90M
Analysts78
Price Target5.9 (288.16%)
Short Float %14.46%
Short Ratio4.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.12%
Min EPS beat(2)-17.65%
Max EPS beat(2)-14.59%
EPS beat(4)0
Avg EPS beat(4)-23.22%
Min EPS beat(4)-49.39%
Max EPS beat(4)-11.25%
EPS beat(8)0
Avg EPS beat(8)-30.45%
EPS beat(12)1
Avg EPS beat(12)-32.72%
EPS beat(16)1
Avg EPS beat(16)-38.9%
Revenue beat(2)1
Avg Revenue beat(2)-23.42%
Min Revenue beat(2)-64.45%
Max Revenue beat(2)17.62%
Revenue beat(4)1
Avg Revenue beat(4)-15.26%
Min Revenue beat(4)-64.45%
Max Revenue beat(4)17.62%
Revenue beat(8)4
Avg Revenue beat(8)-9.89%
Revenue beat(12)5
Avg Revenue beat(12)-17.57%
Revenue beat(16)5
Avg Revenue beat(16)-27.33%
PT rev (1m)-2.73%
PT rev (3m)12.38%
EPS NQ rev (1m)1.67%
EPS NQ rev (3m)21.33%
EPS NY rev (1m)-2.4%
EPS NY rev (3m)-4.02%
Revenue NQ rev (1m)4.93%
Revenue NQ rev (3m)-25.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 23.34
P/FCF N/A
P/OCF N/A
P/B 0.72
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)-0.34
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0.07
BVpS2.11
TBVpS2.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.17%
ROE -15.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.81%
FCFM N/A
ROA(3y)-11.11%
ROA(5y)-18.09%
ROE(3y)-12.96%
ROE(5y)-21.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 174.5%
Cap/Sales 189.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.25
Quick Ratio 8.05
Altman-Z 0.32
F-Score4
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)784.57%
Cap/Depr(5y)508.73%
Cap/Sales(3y)5816.93%
Cap/Sales(5y)3516.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next Y-19.37%
EPS Next 2Y-1%
EPS Next 3Y-10.96%
EPS Next 5Y45.65%
Revenue 1Y (TTM)16.53%
Revenue growth 3Y45.88%
Revenue growth 5Y-12.14%
Sales Q2Q%-56.6%
Revenue Next Year-12.49%
Revenue Next 2Y198.42%
Revenue Next 3Y137.06%
Revenue Next 5Y66%
EBIT growth 1Y-6.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.56%
EBIT Next 3Y35.3%
EBIT Next 5Y29.52%
FCF growth 1Y33.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-26.23%
OCF growth 3YN/A
OCF growth 5YN/A